Answers are grounded in this paper and cite their sources.
Aims The aims of this study were to assess the feasibility of a randomized controlled trial (RCT) comparing surgical and non-surgical treatment for metacarpal shaft fractures (MSFs), identify appropriate outcome measures for use in a future trial, and provide person-centred insight to inform trial design and identify barriers to participation. Methods We carried out a prospective, multicentre, observational feasibility study at five UK sites, and an embedded qualitative study. Adults (aged ≥ 16 years) with an acute displaced MSF were screened and prospectively recruited between July 2020 and July 2021. Clinical (grip strength, range of motion, and radiological parameters) and patient-reported outcome measures (Patient Evaluation Measure, the abbreviated version of the Disabilities of the Arm, Shoulder and Hand questionnaire (QuickDASH), Patient-Reported Outcomes Measurement Information System Upper Extremity (PROMIS-UE), EQ-5D-5L, and the seven-point Global Rating of Change) were collected at study enrollment, six weeks, and at three, and six months. Semistructured interviews and focus groups were conducted with participants selected from the main study cohort using purposive sampling, and analyzed using a thematic inductive approach. Results Of 5,863 patients screened, 201 were eligible and 108 were recruited. The median age was 32 years (IQR 22 to 48); 68% (n = 73/108) patients were male, 84% (n = 65/108) were treated non-surgically, and 16% (n = 12/108) surgically. Treatment was unknown for 31 patients (29%) who failed to attend the six-week follow-up. Retention was 71% (n = 77/108) at six weeks and 45% (n = 49/108) at six months. In total, 20 interviews were conducted, with 13 participants and three focus groups (eight participants per group). Five key themes and 30 sub-themes were identified. Participants selected the QuickDASH and PROMIS-UE as optimal outcome measures and recommended increased follow-up in the first four to six weeks post-injury. Interventions, data collection methods, and follow-up were acceptable to participants. Conclusion A multicentre RCT comparing surgical and non-surgical management of MSF appears feasible. Recruitment across sites was achievable and suitable primary outcome measures were identified. However, declining retention beyond six weeks highlights the need for targeted strategies to enhance engagement and retention in a definitive trial. Cite this article: Bone Jt Open 2026;7(11):1507–1520.
No takes yet. Share an insight, caveat, or question.
Taha et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: